Why the study?
Parkinson's disease produces autonomic changes indicating lower parasympathetic modulation and global variability, but these changes needed further investigation regarding geometric methods.
Does Parkinson's disease affect autonomic modulation as measured by heart rate variability geometric indices compared to controls?
Does Parkinson's disease affect autonomic modulation as measured by heart rate variability geometric indices compared to controls?
Parkinson's disease is associated with a significant reduction in parasympathetic autonomic modulation and global heart rate variability compared to healthy controls.
Parkinson's disease was associated with reduced HRV geometric indices; leaves open their prognostic value in prospective studies.
BACKGROUND: Parkinson's disease (PD) produces autonomic changes, indicating lower parasympathetic modulation and global variability, but these changes need further studying regarding geometric methods. OBJECTIVE: To investigate the autonomic modulation in individuals with PD using heart rate variability (HRV) indices obtained through geometric methods. METHODS: This is a cross-sectional study that assessed 50 individuals, split into two groups: PD group (PDG; n=26; 75.36±5.21 years) and control group (CG; n=24; 75.36±5.21 years). We evaluated the autonomic modulation by measuring the heart rate beat-to-beat for 30 min with the individual in supine rest using a heart rate monitor and assessed geometric indices (RRtri, TINN, SD1, SD2, SD1/SD2 ratio, and qualitative analysis of the Poincaré plot). RESULTS: Significant reductions were found in RRtri, TINN, SD1, and SD2 indices among PDG compared to CG. Regarding the SD1/SD2 ratio, no significant changes were detected between the groups. The Poincaré plot demonstrated that individuals with PD had lower beat-to-beat dispersion in RR intervals, in addition to greater long-term dispersion of RR intervals compared to CG. CONCLUSIONS: The results suggest a reduction in the parasympathetic autonomic modulation and global variability in individuals with PD compared to controls, regardless of sex, age, and body mass index.
No takes yet. Share an insight, caveat, or question.
Stoco-Oliveira et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: